Recent studies have shown that AdipoRon exerts adiponectin-like effects in diseases such as diabetes and obesity and compensates for the limitations of adiponectin in clinical applications [33]. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.